129 related articles for article (PubMed ID: 31571206)
1. Blinding and bias in randomized controlled trials: when to measure the effectiveness of blinding.
Copeland L; Edwards P; Sakzewski L; Thorley M; Kentish M; Ware RS; Boyd RN
Dev Med Child Neurol; 2020 Feb; 62(2):260. PubMed ID: 31571206
[No Abstract] [Full Text] [Related]
2. Botulinum neurotoxin A, blinding, and bias.
Hastings-Ison T; Graham K
Dev Med Child Neurol; 2020 Feb; 62(2):259. PubMed ID: 31225641
[No Abstract] [Full Text] [Related]
3. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.
Ubhi T; Bhakta BB; Ives HL; Allgar V; Roussounis SH
Arch Dis Child; 2000 Dec; 83(6):481-7. PubMed ID: 11087280
[TBL] [Abstract][Full Text] [Related]
4. Preoperative treatment of spasticity with botulinum neurotoxin A to reduce pain in cerebral palsy: is it worthwhile?
Gormley M
Dev Med Child Neurol; 2019 Sep; 61(9):997. PubMed ID: 30761520
[No Abstract] [Full Text] [Related]
5. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
[TBL] [Abstract][Full Text] [Related]
6. Success or failure of blinding in randomized controlled trials.
Day SM
Dev Med Child Neurol; 2020 Feb; 62(2):159. PubMed ID: 31670394
[No Abstract] [Full Text] [Related]
7. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
8. Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial.
Kim K; Shin HI; Kwon BS; Kim SJ; Jung IY; Bang MS
Dev Med Child Neurol; 2011 Mar; 53(3):239-44. PubMed ID: 21087238
[TBL] [Abstract][Full Text] [Related]
9. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy-A Secondary Analysis of the Randomized Clinical Trial.
Hong BY; Chang HJ; Lee SJ; Lee S; Park JH; Kwon JY
Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28825663
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study.
Baker R; Jasinski M; Maciag-Tymecka I; Michalowska-Mrozek J; Bonikowski M; Carr L; MacLean J; Lin JP; Lynch B; Theologis T; Wendorff J; Eunson P; Cosgrove A
Dev Med Child Neurol; 2002 Oct; 44(10):666-75. PubMed ID: 12418791
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.
O'Donnell ME
J Pediatr; 2001 Jul; 139(1):163. PubMed ID: 11463048
[No Abstract] [Full Text] [Related]
13. Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.
Copeland L; Edwards P; Thorley M; Donaghey S; Gascoigne-Pees L; Kentish M; Cert G; Lindsley J; McLennan K; Sakzewski L; Boyd RN
J Pediatr; 2014 Jul; 165(1):140-146.e4. PubMed ID: 24630348
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum toxin--interventional neuropediatrics in spastic movement disorders in childhood].
Berweck S; Heinen F
Kinderkrankenschwester; 2003 Mar; 22(3):95-100. PubMed ID: 15984440
[TBL] [Abstract][Full Text] [Related]
15. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy.
Sutherland DH; Kaufman KR; Wyatt MP; Chambers HG; Mubarak SJ
Gait Posture; 1999 Sep; 10(1):1-9. PubMed ID: 10469936
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy.
Polak F; Morton R; Ward C; Wallace WA; Doderlein L; Siebel A
Dev Med Child Neurol; 2002 Aug; 44(8):551-5. PubMed ID: 12206622
[TBL] [Abstract][Full Text] [Related]
18. Blinding in randomized controlled trials in general and abdominal surgery: protocol for a systematic review and empirical study.
Probst P; Grummich K; Heger P; Zaschke S; Knebel P; Ulrich A; Büchler MW; Diener MK
Syst Rev; 2016 Mar; 5():48. PubMed ID: 27012940
[TBL] [Abstract][Full Text] [Related]
19. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.
Boyd RN; Hays RM
Eur J Neurol; 2001 Nov; 8 Suppl 5():1-20. PubMed ID: 11851730
[TBL] [Abstract][Full Text] [Related]
20. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
